Financial reports
10-K
2023 FY
Annual report
8 Mar 24
10-Q
2023 Q3
Quarterly report
11 Dec 23
10-K/A
2022 FY
Annual report (amended)
11 Dec 23
NT 10-Q
Notice of late quarterly filing
9 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
14 Apr 23
10-K
2022 FY
Annual report
1 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
1 Aug 22
Current reports
8-K
Emergent Biosolutions Reports Fourth Quarter 2023 Financial Results
6 Mar 24
8-K
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
21 Feb 24
8-K
Other Events
11 Jan 24
8-K
Regulation FD Disclosure
9 Jan 24
8-K
Other Events
28 Nov 23
8-K
Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing
24 Nov 23
8-K
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
16 Nov 23
8-K
Emergent Biosolutions Reports Third Quarter 2023 Financial Results
8 Nov 23
8-K
A Statement on Emergent’s Camden Manufacturing Facility Regulatory Status
5 Oct 23
8-K
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
2 Oct 23
Registration and prospectus
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Dec 23
S-8
Registration of securities for employees
11 Dec 23
S-8
Registration of securities for employees
5 Jun 23
424B5
Prospectus supplement for primary offering
18 May 23
S-3ASR
Automatic shelf registration
9 Aug 21
S-8
Registration of securities for employees
4 Jun 21
D
$47.87M in equity, sold $47.87M, 8 investors
30 Oct 18
S-3ASR
Automatic shelf registration
3 Aug 18
S-8
Registration of securities for employees
30 May 18
S-8
Registration of securities for employees
28 Feb 17
Proxies
DEFR14A
Revised proxy
24 Apr 23
DEFA14A
Additional proxy soliciting materials
14 Apr 23
DEF 14A
Definitive proxy
14 Apr 23
DEFA14A
Additional proxy soliciting materials
15 Apr 22
DEF 14A
Definitive proxy
15 Apr 22
DEFA14A
Additional proxy soliciting materials
9 Apr 21
DEF 14A
Definitive proxy
9 Apr 21
DEFA14A
Additional proxy soliciting materials
9 Apr 20
DEF 14A
Definitive proxy
9 Apr 20
DEFA14A
Additional proxy soliciting materials
12 Apr 19
Other
UPLOAD
Letter from SEC
9 Dec 21
CORRESP
Correspondence with SEC
12 Nov 21
UPLOAD
Letter from SEC
29 Oct 21
CT ORDER
Confidential treatment order
18 Oct 21
CT ORDER
Confidential treatment order
18 Oct 21
CT ORDER
Confidential treatment order
18 Oct 21
CT ORDER
Confidential treatment order
18 Oct 21
CT ORDER
Confidential treatment order
18 Oct 21
CT ORDER
Confidential treatment order
18 Oct 21
CORRESP
Correspondence with SEC
30 Sep 21
Ownership